Status:
COMPLETED
A Recurrence Nomogram for Hepatoid Adenocarcinoma of the Stomach
Lead Sponsor:
Fujian Medical University
Conditions:
Gastric Cancer
Eligibility:
All Genders
Brief Summary
This study aims to develop a nomogram to predict postoperative recurrence of HAS and guide individually tailored surveillance strategies.
Detailed Description
Patients were included from the China Hepatoid Adenocarcinoma of the Stomach Study Group (China-HASSG) database, which comprises 14 tertiary referral centers. All the patients who had undergone comple...
Eligibility Criteria
Inclusion
- Patients who had undergone complete resection of a primary HAS between April 2004 and December 2019
Exclusion
- Patients with metastatic disease, patients who had undergone palliative surgery, patients who had died within 30 days, and patients who were lost to follow-up
Key Trial Info
Start Date :
April 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
261 Patients enrolled
Trial Details
Trial ID
NCT05274464
Start Date
April 1 2004
End Date
December 31 2019
Last Update
March 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fujian Medical University Union Hospital
Fuzhou, Fujian, China, 350001